A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine

Condition:   Herpes Zoster Interventions:   Biological: HZ/su;   Combination Product: Flu D-QIV;   Biological: mRNA-1273 Sponsor:   GlaxoSmithKline Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials